MET and neoplasm: c-Met signaling inhibition disrupted tumor growth and invasion in vitro and in vivo, indicating that c-Met activation may be required for GSC function (Joo et al., 2012), thereby suggesting a promising therapeutic target if also found to be true in HGGs such as DIPG among others (Figure 4).